1. Statutory Text and Distinct Place in Substantive Criminal Law
Section 278 of the Bharatiya Nyaya Sanhita, 2023 (BNS) completes the pharmaceutical triad in Chapter XV by criminalising the knowing substitution or mislabelling of one drug or medical preparation for another S1, s. 278. The enacted Gazette text reads verbatim:
278. Sale of drug as a different drug or preparation.—Whoever knowingly sells, or offers or exposes for sale, or issues from a dispensary for medicinal purposes, any drug or medical preparation, as a different drug or medical preparation, shall be punished with imprisonment of either description for a term which may extend to six months, or with fine which may extend to five thousand rupees, or with both. S1, s. 278
The Crucial Legal Distinction Between Sections 276–277 and Section 278 BNS
Practitioners and students frequently conflate Section 277 BNS (Sale of adulterated drugs) with Section 278 BNS (Sale of drug as a different drug or preparation). The substantive distinction is fundamental S1, ss. 276–278:
- Under Sections 276 and 277 BNS, the drug itself must have been adulterated (mixed, diluted, or chemically altered so as to lessen its efficacy, change its operation, or render it noxious) S1, ss. 276, 277.
- Under Section 278 BNS, the drug or medical preparation sold or dispensed need not be adulterated, impure, or noxious at all S1, s. 278. Even if Drug $X$ (say, pure paracetamol) is 100% genuine and chemically unblemished, knowingly selling, exposing for sale, or issuing Drug $X$ from a dispensary as Drug $Y$ (say, as an anti-epileptic or cardiac drug) commits the offence under Section 278 BNS S1, s. 278; S7, paras 6–10. The mischief targeted by Section 278 is therapeutic substitution and misrepresentation of medicinal identity, which deprives the patient of the intended medicine and exposes them to the unconsented pharmacological action of a different substance.
2. Exact Offence Ingredients and Mental Element (Mens Rea)
To establish an offence under Section 278 BNS, the prosecution must prove three cumulative ingredients S1, s. 278:
- Subject Matter (Any Drug or Medical Preparation):
- The article involved must be a drug or medical preparation, whether allopathic, ayurvedic, unani, siddha, homoeopathic, or compounded clinical formulation S1, s. 278; S7, paras 6–10.
- Prohibited Conduct and False Identity Representation (Actus Reus):
- The accused must:
- (a) sell,
- (b) offer or expose for sale, or
- (c) issue from a dispensary for medicinal purposes that drug or medical preparation as a different drug or medical preparation S1, s. 278.
- Note that, unlike Section 277 BNS (which has a fourth limb covering "causes it to be used for medicinal purposes by any person"), Section 278 BNS is confined to the three commercial/dispensary channels: selling, offering/exposing for sale, and issuing from a dispensary for medicinal purposes S1, ss. 277, 278.
- Furthermore, the offence does not require proof of pecuniary loss to the buyer (unlike cheating under Section 318 BNS) or actual physical hurt to the patient; even if the substituted preparation happens to be more expensive or harmless, the offence is complete upon the knowing sale, offer/exposure, or dispensary issue as a different drug S1, ss. 278, 318.
- The accused must:
- Mental Element ("Knowingly"):
- The adverb "knowingly" governs the entire predicate S1, s. 278. The accused must know both (i) the true nature/identity of the drug or preparation being supplied (or at least that it is not the drug represented) and (ii) that it is being sold, offered/exposed for sale, or issued as a different drug or medical preparation S1, s. 278.
- Honest Dispensing Mistake vs. Knowing Substitution: If a pharmacist, through an honest visual mistake in reading a physician's handwritten prescription or by accidentally picking a look-alike bottle in good faith, dispenses the wrong medicine without knowing it is a different drug, Section 278 BNS is not attracted because the act was not done knowingly S1, ss. 3(1), 17, 278. (Note, however, that if the substance is poisonous and the pharmacist's conduct is rash or negligent so as to endanger human life, liability may separately arise under Section 286 BNS, or if hurt/death ensues, under Sections 125 or 106 BNS S1, ss. 106, 125, 286.)
3. IPC-to-BNS Correspondence and Statutory Comparison
Section 278 BNS directly replaces Section 276 of the Indian Penal Code, 1860 (IPC) S4, s. 276; S5:
| Attribute | IPC Section 276 (Repealed w.e.f. 01-07-2024) | BNS Section 278 (Effective 01-07-2024) | Legal & Practical Significance |
|---|---|---|---|
| Section Number & Heading | Section 276: Sale of drug as a different drug or preparation. S4, s. 276 | Section 278: Sale of drug as a different drug or preparation. S1, s. 278 | Renumbered by +2 in Chapter XV of the BNS (Note: do not confuse old IPC 276 with new BNS 276, which is old IPC 274!) S5. |
| Operative Ingredients | Knowingly sells, offers/exposes for sale, or issues from a dispensary for medicinal purposes any drug or medical preparation as a different drug or preparation S4, s. 276 | Identical verbatim wording S1, s. 278 | Zero change in substantive ingredients or mental standard ("knowingly") S1, s. 278; S4, s. 276. |
| Maximum Imprisonment | Imprisonment of either description up to six months S4, s. 276 | Imprisonment of either description up to six months S1, s. 278 | Unchanged S1, s. 278; S4, s. 276. |
| Maximum Fine | Up to ₹1,000 ("one thousand rupees") S4, s. 276 | Up to ₹5,000 ("five thousand rupees") S1, s. 278 | Five-fold increase in statutory fine ceiling S1, s. 278; S4, s. 276. |
| Default-of-Fine Imprisonment | Up to 1.5 months (under Section 65 IPC) S4, s. 65 | Up to 1.5 months (one-fourth of 6 months under Section 8(3) BNS) S1, s. 8(3) | Unchanged S1, s. 8(3). |
Practitioner Citation Alert: Because Section 276 IPC was renumbered to Section 278 BNS, while Section 274 IPC became Section 276 BNS, FIRs, complaints, and charge-sheets must carefully verify whether the allegation is adulteration (now Section 276 BNS) or sale as a different drug (now Section 278 BNS) S1, ss. 276, 278; S5.
4. Punishment Matrix and Sentencing Mechanics
- Imprisonment: Up to six months of either description (rigorous or simple, or partly rigorous and partly simple under Section 7 BNS) S1, ss. 7, 278.
- Fine: Discretionary ("or with fine... or with both"), up to ₹5,000 S1, s. 278.
- Imprisonment in Default of Payment of Fine: Under Section 8(3) BNS, capped at one-fourth of the maximum imprisonment (i.e., 1.5 months), of either description per Section 8(4) BNS S1, s. 8(3)–(4).
5. Procedural Classification (BNSS 2023) and Special-Law Overlap
Under the First Schedule to the BNSS, 2023, Section 278 BNS is classified as S2, First Schedule:
- Non-cognizable: Requires a Magistrate's order under Section 174(2) BNSS for police investigation S2, s. 174, First Schedule.
- Bailable: Bailable as of right S2, First Schedule.
- Triable by Any Magistrate S2, First Schedule. (Note: While Section 283(1)(i) BNSS specifically names Sections 276 and 277 BNS, Section 278 BNS is also eligible for summary trial by a Chief Judicial Magistrate or Magistrate of the first class under the general clause Section 283(1)(a) BNSS, which covers offences not punishable with death, life imprisonment, or imprisonment for a term exceeding three years S2, s. 283(1)(a), (i).)
- Non-compoundable under Section 359 BNSS S2, s. 359.
Overlap with Cheating (Section 318 BNS) and Drugs and Cosmetics Act, 1940:
- Where a seller knowingly passes off a cheap generic preparation as a costly branded biologic to deceive a buyer into paying a higher price, the conduct may simultaneously satisfy Section 278 BNS and Section 318 BNS (Cheating), subject to the single-punishment limit in Section 9 BNS S1, ss. 9, 278, 318.
- Under the Drugs and Cosmetics Act, 1940, a drug sold under a name which belongs to another drug, or which is an imitation of or a substitute for another drug, is defined as a "spurious drug" under Section 17B (and/or "misbranded" under Section 17), attracting stringent penalties under Section 27 of that Act S6. Pursuant to Union of India v. Ashok Kumar Sharma, (2021) 12 SCC 674, prosecutions under Chapter IV of the 1940 Act are governed by the special complaint mechanism in Section 32 of that Act S6, paras 150–170.
6. Temporal Applicability
Section 278 BNS commenced on 1 July 2024 S3. Offences committed prior to 1 July 2024 must be tried under Section 276 IPC (with the ₹1,000 fine cap) in accordance with Section 358(2) BNS and Article 20(1) of the Constitution, whereas conduct on or after 1 July 2024 is governed by Section 278 BNS (with the ₹5,000 fine cap) S1, ss. 278, 358(2); S4, s. 276.
7. Practical Illustrations and Counterexamples
- Editorial Hypothetical 1 (Intentional Substitution of Out-of-Stock Medicine: Offence Committed): P, a dispensary pharmacist, runs out of a prescribed anti-hypertensive drug (Amlodipine). Rather than turning the patient away, P knowingly strips the outer packaging from a mild vitamin tablet of identical size and colour, places it in a dispensary envelope labelled Amlodipine, and issues it to the patient. Even though the vitamin tablet is pure and non-toxic, P knowingly issued a drug as a different drug for medicinal purposes and is guilty under Section 278 BNS S1, s. 278.
- Editorial Hypothetical 2 (Substitution of Herbal/Unani Preparation: Offence Committed): Q, a vendor of traditional medical preparations, knowingly fills bottles labelled "Pure Ashwagandha Extract for Medicinal Use" with a cheaper, entirely different herbal extract (Shatavari) and exposes them for sale in his shop. Q is liable under Section 278 BNS S1, s. 278.
- Editorial Counterexample 1 (Informed Generic Substitution with Patient Consent: No Offence): R, a chemist, informs a customer that Brand A of Azithromycin 500mg is out of stock and offers Brand B of Azithromycin 500mg, clearly billing and handing it over as Brand B. Because R did not sell or represent Brand B as Brand A or as a different drug, no offence under Section 278 BNS is committed S1, s. 278.
- Editorial Counterexample 2 (Inadvertent Picking Error: No Offence Under Section 278 BNS): During a rush hour, Chemist S accidentally picks up a box of Losartan instead of Levocetirizine due to adjacent shelving and hands it to a customer believing it to be Levocetirizine. Because S did not act knowingly, Section 278 BNS is not attracted S1, s. 278.